| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | 14-3-3 protein binding | 1.19e-06 | 42 | 165 | 6 | GO:0071889 | |
| GeneOntologyMolecularFunction | structural constituent of nuclear pore | 1.69e-06 | 25 | 165 | 5 | GO:0017056 | |
| GeneOntologyMolecularFunction | benzodiazepine receptor binding | 5.47e-06 | 5 | 165 | 3 | GO:0030156 | |
| GeneOntologyMolecularFunction | protein serine kinase activity | SMG1 NEK10 HIPK1 BRSK2 RIPK4 TTBK1 BRAF PRKAA2 MAP3K9 SRPK3 BRSK1 MAP3K21 | 5.08e-05 | 363 | 165 | 12 | GO:0106310 |
| GeneOntologyMolecularFunction | nuclear localization sequence binding | 6.80e-05 | 27 | 165 | 4 | GO:0008139 | |
| GeneOntologyMolecularFunction | signaling adaptor activity | 9.95e-05 | 129 | 165 | 7 | GO:0035591 | |
| GeneOntologyMolecularFunction | chromatin binding | MKRN4P FOXO3 ASXL1 ERCC6 CENPF NSD2 MKRN1 CHD8 NUP62 ATAD2 CCNT2 TGIF1 NFKB1 PRKAA2 DMRT1 POLQ CRAMP1 | 1.37e-04 | 739 | 165 | 17 | GO:0003682 |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | SMG1 NEK10 HIPK1 BRSK2 RIPK4 TTBK1 BRAF PRKAA2 MAP3K9 SRPK3 BRSK1 MAP3K21 | 3.46e-04 | 446 | 165 | 12 | GO:0004674 |
| GeneOntologyMolecularFunction | kinase binding | DAB2IP FOXO3 IL12RB2 CEACAM5 TICAM1 PARP8 KIF1B BRSK2 RELB ITGAX SPRED3 CCNT2 TGIF1 BRAF MAVS RPTOR IRS2 BRSK1 WWC1 | 4.23e-04 | 969 | 165 | 19 | GO:0019900 |
| GeneOntologyMolecularFunction | tau-protein kinase activity | 7.60e-04 | 22 | 165 | 3 | GO:0050321 | |
| GeneOntologyMolecularFunction | signal sequence binding | 8.30e-04 | 51 | 165 | 4 | GO:0005048 | |
| GeneOntologyMolecularFunction | SH3 domain binding | 1.22e-03 | 143 | 165 | 6 | GO:0017124 | |
| GeneOntologyMolecularFunction | MAP kinase kinase kinase activity | 1.40e-03 | 27 | 165 | 3 | GO:0004709 | |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | DAB2IP SHANK1 ZXDC ASXL1 TCOF1 HIPK1 TICAM1 NACA NUP62 BCL3 SRCAP ANKRD13A TSC22D1 MAVS RPTOR NFKB1 PRKAA2 IRS2 CAMTA1 WWC1 | 1.46e-03 | 1160 | 165 | 20 | GO:0030674 |
| GeneOntologyMolecularFunction | protein kinase activator activity | 1.51e-03 | 149 | 165 | 6 | GO:0030295 | |
| GeneOntologyBiologicalProcess | synaptic vesicle localization | 2.23e-05 | 71 | 165 | 6 | GO:0097479 | |
| GeneOntologyBiologicalProcess | regulation of small GTPase mediated signal transduction | DAB2IP ARHGAP23 ADGRG1 NUP62 KANK2 MADD ARHGAP6 HEG1 RIPOR1 DNMBP ARHGAP21 | 7.96e-05 | 333 | 165 | 11 | GO:0051056 |
| GeneOntologyBiologicalProcess | RNA transport | 8.47e-05 | 175 | 165 | 8 | GO:0050658 | |
| GeneOntologyBiologicalProcess | nucleic acid transport | 8.47e-05 | 175 | 165 | 8 | GO:0050657 | |
| GeneOntologyBiologicalProcess | establishment of RNA localization | 9.54e-05 | 178 | 165 | 8 | GO:0051236 | |
| GeneOntologyBiologicalProcess | RNA export from nucleus | 1.22e-04 | 96 | 165 | 6 | GO:0006405 | |
| GeneOntologyBiologicalProcess | mRNA transport | 1.69e-04 | 145 | 165 | 7 | GO:0051028 | |
| GeneOntologyBiologicalProcess | protein localization to organelle | EPS15 RNF31 SZT2 NACA NUP62 NUP214 NUP58 BCL3 SIX4 MICALL1 ANKRD13A VPS13D OXA1L MAVS PRKAA2 NPAP1 RIPOR1 LZTS2 TNKS2 MMP12 POM121B | 1.72e-04 | 1091 | 165 | 21 | GO:0033365 |
| GeneOntologyBiologicalProcess | protein import into nucleus | 1.79e-04 | 195 | 165 | 8 | GO:0006606 | |
| GeneOntologyBiologicalProcess | peptidyl-serine phosphorylation | 1.89e-04 | 307 | 165 | 10 | GO:0018105 | |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization involved in establishment of planar polarity | 1.90e-04 | 3 | 165 | 2 | GO:0090176 | |
| GeneOntologyBiologicalProcess | neuromuscular synaptic transmission | 1.90e-04 | 36 | 165 | 4 | GO:0007274 | |
| GeneOntologyCellularComponent | centrosome | CENPF PODXL HIPK1 CEP295NL UBR4 BRSK2 IST1 RELB NUP62 BIRC6 CNTROB CEP164 GLE1 RAB11FIP5 LZTS2 TNKS2 BRSK1 PIK3R5 PDZD2 | 1.34e-05 | 770 | 167 | 19 | GO:0005813 |
| GeneOntologyCellularComponent | microtubule organizing center | CENPF PODXL HIPK1 CEP295NL UBR4 BRSK2 IST1 RELB NUP62 SPECC1 BIRC6 CNTROB CEP164 GLE1 RAB11FIP5 LZTS2 TNKS2 BRSK1 AGBL2 PIK3R5 PDZD2 | 1.45e-05 | 919 | 167 | 21 | GO:0005815 |
| GeneOntologyCellularComponent | nuclear pore | 1.61e-04 | 101 | 167 | 6 | GO:0005643 | |
| GeneOntologyCellularComponent | Flemming body | 1.90e-04 | 36 | 167 | 4 | GO:0090543 | |
| GeneOntologyCellularComponent | Golgi lumen | 2.44e-04 | 109 | 167 | 6 | GO:0005796 | |
| GeneOntologyCellularComponent | I-kappaB/NF-kappaB complex | 3.77e-04 | 4 | 167 | 2 | GO:0033256 | |
| GeneOntologyCellularComponent | midbody | 4.26e-04 | 222 | 167 | 8 | GO:0030496 | |
| GeneOntologyCellularComponent | NF-kappaB complex | 6.24e-04 | 5 | 167 | 2 | GO:0071159 | |
| HumanPheno | Gastroesophageal reflux | ASXL1 ERCC6 UBE4B SZT2 NSD2 APC2 HECTD4 ADGRG1 MUC5B NUP62 NUP214 SRCAP WDR26 TGIF1 BRAF CELF2 SYNJ1 TMEM270 CACNA1I CAMTA1 | 7.72e-08 | 517 | 53 | 20 | HP:0002020 |
| HumanPheno | Abnormal stomach morphology | ASXL1 ERCC6 UBE4B SZT2 PODXL NSD2 APC2 HECTD4 ADGRG1 MUC5B NUP62 NUP214 SRCAP WDR26 TGIF1 BRAF CELF2 SYNJ1 NFKB1 TMEM270 CACNA1I CAMTA1 TNXB | 3.35e-07 | 742 | 53 | 23 | HP:0002577 |
| HumanPheno | Abnormal esophagus physiology | ASXL1 ERCC6 UBE4B SZT2 NSD2 APC2 HECTD4 ADGRG1 MUC5B NUP62 NUP214 SRCAP WDR26 SLC1A3 MADD TGIF1 BRAF CELF2 SYNJ1 GLE1 TMEM270 CACNA1I CAMTA1 PIK3R5 PRPH | 1.31e-06 | 933 | 53 | 25 | HP:0025270 |
| HumanPheno | Abnormal esophagus morphology | ASXL1 ERCC6 TCOF1 UBE4B SZT2 NSD2 IARS1 APC2 HECTD4 ADGRG1 MUC5B NUP62 NUP214 SRCAP WDR26 SLC1A3 MADD TGIF1 BRAF CELF2 SYNJ1 GLE1 TMEM270 CACNA1I CAMTA1 PIK3R5 PRPH | 1.42e-06 | 1078 | 53 | 27 | HP:0002031 |
| HumanPheno | Functional abnormality of the gastrointestinal tract | ASXL1 ERCC6 UBE4B SZT2 IL37 NSD2 IARS1 APC2 HECTD4 ADGRG1 MUC5B NUP62 NUP214 SRCAP WDR26 SLC1A3 MADD TGIF1 BRAF CELF2 SYNJ1 GLE1 TMEM270 CACNA1I CAMTA1 TNXB PIK3R5 PRPH | 1.11e-05 | 1270 | 53 | 28 | HP:0012719 |
| HumanPheno | Constipation | UBE4B PODXL NSD2 APC2 CHD8 SRCAP WDR26 SLC1A3 MADD TGIF1 BRAF SYNJ1 NPAP1 TMEM270 CAMTA1 | 5.79e-05 | 472 | 53 | 15 | HP:0002019 |
| HumanPheno | Flushing | 1.11e-04 | 47 | 53 | 5 | HP:0031284 | |
| Domain | SH3_9 | 5.32e-06 | 78 | 163 | 7 | PF14604 | |
| Domain | UBA | 5.43e-05 | 47 | 163 | 5 | PS50030 | |
| Domain | SH3_2 | 1.06e-04 | 86 | 163 | 6 | PF07653 | |
| Domain | SH3_2 | 1.06e-04 | 86 | 163 | 6 | IPR011511 | |
| Domain | SH3 | SHANK1 RIMBP3 SH3PXD2A MAP3K9 RIMBP3C RIMBP3B MAP3K21 DNMBP SH3RF3 | 1.20e-04 | 216 | 163 | 9 | SM00326 |
| Domain | SH3 | SHANK1 RIMBP3 SH3PXD2A MAP3K9 RIMBP3C RIMBP3B MAP3K21 DNMBP SH3RF3 | 1.20e-04 | 216 | 163 | 9 | PS50002 |
| Domain | DUF4599 | 1.36e-04 | 12 | 163 | 3 | PF15371 | |
| Domain | DUF4599 | 1.36e-04 | 12 | 163 | 3 | IPR027970 | |
| Domain | SH3_domain | SHANK1 RIMBP3 SH3PXD2A MAP3K9 RIMBP3C RIMBP3B MAP3K21 DNMBP SH3RF3 | 1.38e-04 | 220 | 163 | 9 | IPR001452 |
| Domain | PL48 | 2.26e-04 | 3 | 163 | 2 | PF15903 | |
| Domain | FAM65_N | 2.26e-04 | 3 | 163 | 2 | IPR031780 | |
| Domain | FAM65 | 2.26e-04 | 3 | 163 | 2 | IPR026136 | |
| Domain | VWF_type-D | 3.36e-04 | 16 | 163 | 3 | IPR001846 | |
| Domain | VWFD | 3.36e-04 | 16 | 163 | 3 | PS51233 | |
| Domain | VWD | 3.36e-04 | 16 | 163 | 3 | SM00216 | |
| Domain | VWD | 3.36e-04 | 16 | 163 | 3 | PF00094 | |
| Domain | PDZ | 3.65e-04 | 151 | 163 | 7 | PS50106 | |
| Domain | PDZ | 3.80e-04 | 152 | 163 | 7 | IPR001478 | |
| Domain | ANK_REPEAT | 3.90e-04 | 253 | 163 | 9 | PS50088 | |
| Domain | ANK_REP_REGION | 4.01e-04 | 254 | 163 | 9 | PS50297 | |
| Domain | MLK1/MLK2/MLK4 | 4.49e-04 | 4 | 163 | 2 | IPR016231 | |
| Domain | MAP3K10 | 4.49e-04 | 4 | 163 | 2 | IPR015785 | |
| Domain | UBA | 5.78e-04 | 44 | 163 | 4 | IPR015940 | |
| Domain | IPT_NFkappaB | 7.44e-04 | 5 | 163 | 2 | IPR033926 | |
| Domain | RHD_CS | 7.44e-04 | 5 | 163 | 2 | IPR030492 | |
| Domain | SEA | 8.90e-04 | 22 | 163 | 3 | PF01390 | |
| Domain | Ank | 8.96e-04 | 228 | 163 | 8 | PF00023 | |
| Domain | SEA | 1.02e-03 | 23 | 163 | 3 | PS50024 | |
| Domain | SEA_dom | 1.02e-03 | 23 | 163 | 3 | IPR000082 | |
| Domain | Liprin | 1.11e-03 | 6 | 163 | 2 | IPR029515 | |
| Domain | Ser/Thr_kinase_AS | HIPK1 BRSK2 RIPK4 TTBK1 BRAF PRKAA2 MAP3K9 SRPK3 BRSK1 MAP3K21 | 1.19e-03 | 357 | 163 | 10 | IPR008271 |
| Domain | S_TKc | NEK10 HIPK1 BRSK2 TTBK1 BRAF PRKAA2 MAP3K9 SRPK3 BRSK1 MAP3K21 | 1.24e-03 | 359 | 163 | 10 | SM00220 |
| Domain | PROTEIN_KINASE_ST | HIPK1 BRSK2 RIPK4 TTBK1 BRAF PRKAA2 MAP3K9 SRPK3 BRSK1 MAP3K21 | 1.32e-03 | 362 | 163 | 10 | PS00108 |
| Domain | ANK | 1.65e-03 | 251 | 163 | 8 | SM00248 | |
| Domain | FN3 | 1.85e-03 | 199 | 163 | 7 | PS50853 | |
| Domain | Protein_kinase_ATP_BS | NEK10 HIPK1 BRSK2 TTBK1 BRAF PRKAA2 MAP3K9 SRPK3 BRSK1 MAP3K21 | 1.86e-03 | 379 | 163 | 10 | IPR017441 |
| Domain | PDZ | 1.92e-03 | 148 | 163 | 6 | SM00228 | |
| Domain | Pkinase | NEK10 HIPK1 BRSK2 RIPK4 TTBK1 BRAF PRKAA2 MAP3K9 SRPK3 BRSK1 | 1.93e-03 | 381 | 163 | 10 | PF00069 |
| Domain | - | 2.05e-03 | 150 | 163 | 6 | 2.30.42.10 | |
| Domain | Ankyrin_rpt | 2.16e-03 | 262 | 163 | 8 | IPR002110 | |
| Domain | PROTEIN_KINASE_ATP | NEK10 HIPK1 BRSK2 RIPK4 TTBK1 BRAF PRKAA2 MAP3K9 SRPK3 BRSK1 MAP3K21 | 2.37e-03 | 459 | 163 | 11 | PS00107 |
| Domain | FN3_dom | 2.43e-03 | 209 | 163 | 7 | IPR003961 | |
| Domain | TIG | 2.45e-03 | 31 | 163 | 3 | PF01833 | |
| Domain | ARM-like | 2.60e-03 | 270 | 163 | 8 | IPR011989 | |
| Domain | SNF2_N | 2.69e-03 | 32 | 163 | 3 | IPR000330 | |
| Domain | IPT | 2.69e-03 | 32 | 163 | 3 | IPR002909 | |
| Domain | SNF2_N | 2.69e-03 | 32 | 163 | 3 | PF00176 | |
| Domain | Kinase-like_dom | SMG1 NEK10 HIPK1 BRSK2 RIPK4 TTBK1 BRAF PRKAA2 MAP3K9 SRPK3 BRSK1 MAP3K21 | 2.91e-03 | 542 | 163 | 12 | IPR011009 |
| Domain | RHD_dimer | 3.25e-03 | 10 | 163 | 2 | IPR032397 | |
| Domain | RHD_dimer | 3.25e-03 | 10 | 163 | 2 | PF16179 | |
| Domain | REL_1 | 3.25e-03 | 10 | 163 | 2 | PS01204 | |
| Domain | IPPc | 3.25e-03 | 10 | 163 | 2 | IPR000300 | |
| Domain | - | 3.25e-03 | 10 | 163 | 2 | 2.60.40.340 | |
| Domain | IPPc | 3.25e-03 | 10 | 163 | 2 | SM00128 | |
| Domain | NFkB/Dor | 3.25e-03 | 10 | 163 | 2 | IPR000451 | |
| Domain | RHD_DNA_bind_dom | 3.25e-03 | 10 | 163 | 2 | IPR011539 | |
| Domain | RHD_DNA_bind | 3.25e-03 | 10 | 163 | 2 | PF00554 | |
| Domain | REL_2 | 3.25e-03 | 10 | 163 | 2 | PS50254 | |
| Domain | - | 3.40e-03 | 222 | 163 | 7 | 1.25.10.10 | |
| Domain | UBA | 3.77e-03 | 36 | 163 | 3 | PF00627 | |
| Domain | Prot_kinase_dom | NEK10 HIPK1 BRSK2 RIPK4 TTBK1 BRAF PRKAA2 MAP3K9 SRPK3 BRSK1 MAP3K21 | 3.83e-03 | 489 | 163 | 11 | IPR000719 |
| Domain | PROTEIN_KINASE_DOM | NEK10 HIPK1 BRSK2 RIPK4 TTBK1 BRAF PRKAA2 MAP3K9 SRPK3 BRSK1 MAP3K21 | 4.07e-03 | 493 | 163 | 11 | PS50011 |
| Domain | BROMODOMAIN_1 | 4.08e-03 | 37 | 163 | 3 | PS00633 | |
| Domain | Bromodomain | 4.40e-03 | 38 | 163 | 3 | PF00439 | |
| Domain | C8 | 4.72e-03 | 12 | 163 | 2 | PF08742 | |
| Domain | TIL | 4.72e-03 | 12 | 163 | 2 | PF01826 | |
| Domain | BROMODOMAIN_2 | 5.46e-03 | 41 | 163 | 3 | PS50014 | |
| Domain | Unchr_dom_Cys-rich | 5.54e-03 | 13 | 163 | 2 | IPR014853 | |
| Domain | C8 | 5.54e-03 | 13 | 163 | 2 | SM00832 | |
| Domain | FN3 | 5.74e-03 | 185 | 163 | 6 | SM00060 | |
| Domain | Bromodomain | 5.84e-03 | 42 | 163 | 3 | IPR001487 | |
| Domain | BROMO | 5.84e-03 | 42 | 163 | 3 | SM00297 | |
| Domain | - | 5.84e-03 | 42 | 163 | 3 | 1.20.920.10 | |
| Domain | - | 6.19e-03 | 248 | 163 | 7 | 1.25.40.20 | |
| Domain | SAM_2 | 6.24e-03 | 43 | 163 | 3 | PF07647 | |
| Domain | TIL_dom | 6.43e-03 | 14 | 163 | 2 | IPR002919 | |
| Domain | IBR | 6.43e-03 | 14 | 163 | 2 | PF01485 | |
| Domain | SEA | 6.43e-03 | 14 | 163 | 2 | SM00200 | |
| Domain | IBR | 6.43e-03 | 14 | 163 | 2 | SM00647 | |
| Domain | Ankyrin_rpt-contain_dom | 7.02e-03 | 254 | 163 | 7 | IPR020683 | |
| Domain | IBR_dom | 7.38e-03 | 15 | 163 | 2 | IPR002867 | |
| Domain | Rho_GTPase_activation_prot | 7.39e-03 | 88 | 163 | 4 | IPR008936 | |
| Domain | SAM | 7.39e-03 | 88 | 163 | 4 | SM00454 | |
| Domain | PDZ | 7.95e-03 | 141 | 163 | 5 | PF00595 | |
| Domain | Znf_PHD | 8.30e-03 | 91 | 163 | 4 | IPR001965 | |
| Domain | ZnF_C3H1 | 8.47e-03 | 48 | 163 | 3 | SM00356 | |
| Pathway | REACTOME_DEFECTIVE_GALNT3_CAUSES_HFTC | 7.59e-06 | 16 | 117 | 4 | M27410 | |
| Pathway | REACTOME_DEFECTIVE_C1GALT1C1_CAUSES_TNPS | 9.87e-06 | 17 | 117 | 4 | M27412 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 3.53e-05 | 23 | 117 | 4 | M556 | |
| Pathway | REACTOME_DECTIN_2_FAMILY | 5.85e-05 | 26 | 117 | 4 | M27483 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NUCLEAR_EXPORT_OF_MRNA | 1.05e-04 | 30 | 117 | 4 | M47752 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | FOXO3 SHROOM3 UBAP2 PARP8 KIF1B BRSK2 CCDC85C NUP62 SPECC1 WDR26 MADD MICALL1 VPS13D BRAF SYNJ1 ZFP36L1 SH3PXD2A PHF3 RPTOR PRKAA2 MAP3K9 RAB11FIP5 SRPK3 IRS2 MAP3K21 DNMBP SH3RF3 GARRE1 ARHGAP21 OTOG | 4.22e-17 | 861 | 172 | 30 | 36931259 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | DAB2IP FOXO3 ZXDC SHROOM3 UBE4B SZT2 NSD2 UBR4 HECTD4 CHD8 RELB NUP214 CORO1B SRCAP BIRC6 CNTROB MADD MICALL1 HIVEP3 HEG1 SYNJ1 RPTOR RIPOR1 IRS2 MRPL46 DNMBP MYRF ARHGAP21 CRAMP1 | 2.06e-13 | 1105 | 172 | 29 | 35748872 |
| Pubmed | FOXO3 SHROOM3 PARP8 KIF1B CCDC85C BIRC6 CNTROB BRAF TBC1D22A SH3PXD2A DNAJC11 CPEB4 IRS2 LZTS2 MAP3K21 SH3RF3 GARRE1 WWC1 | 1.11e-11 | 446 | 172 | 18 | 24255178 | |
| Pubmed | SMG1 SHROOM3 UBAP2 SZT2 NSD2 NACA HECTD4 CHD8 NUP58 GMEB2 MICALL1 RPTOR RAB11FIP5 BOP1 LZTS2 DNMBP GARRE1 CRAMP1 | 1.78e-10 | 529 | 172 | 18 | 14621295 | |
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | DAB2IP FOXO3 EPS15 TCOF1 CDKN2AIP TICAM1 CCDC85C RELB FCHO2 KANK2 CNTROB MADD ANKRD13A GORASP2 ZFP36L1 RPTOR NFKB1 DNAJC11 RAB11FIP5 RIPOR1 IRS2 LZTS2 ARHGAP21 WWC1 | 3.89e-10 | 1038 | 172 | 24 | 26673895 |
| Pubmed | DAB2IP SHANK1 EPS15 SHROOM3 UBAP2 TCOF1 PRR36 CENPF UBR4 APC2 HECTD4 CHD8 CORO1B PPFIA3 KANK2 WDR26 SLC1A3 CNTNAP5 SYNJ1 RPTOR BRSK1 ARHGAP21 | 2.79e-09 | 963 | 172 | 22 | 28671696 | |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | DAB2IP EPS15 SHROOM3 UBAP2 ARHGAP23 CCDC85C IST1 NUP214 CORO1B KANK2 SPECC1 MICALL1 GORASP2 MAVS SYNJ1 LZTS2 ARHGAP21 | 3.70e-09 | 565 | 172 | 17 | 25468996 |
| Pubmed | 8.60e-09 | 6 | 172 | 4 | 20850414 | ||
| Pubmed | Targeted disruption of the spermatid-specific gene Spata31 causes male infertility. | 8.60e-09 | 6 | 172 | 4 | 25930072 | |
| Pubmed | DAB2IP EPS15 METTL3 ERCC6 TCOF1 CENPF CHD8 FCHO2 GORASP2 BRAF MAVS PHF3 RPTOR BOP1 IRS2 | 3.60e-08 | 503 | 172 | 15 | 16964243 | |
| Pubmed | EPS15 METTL3 SHROOM3 CEACAM5 ERCC6 NSD2 CDKN2AIP MKRN1 NACA IST1 ADGRG1 CHD8 NUP62 SIX4 ATAD2 KANK2 SPECC1 CEP164 GORASP2 PHF3 DNAJC11 BOP1 LZTS2 DNMBP SDC1 | 1.05e-07 | 1497 | 172 | 25 | 31527615 | |
| Pubmed | Probing nuclear pore complex architecture with proximity-dependent biotinylation. | 1.15e-07 | 77 | 172 | 7 | 24927568 | |
| Pubmed | DAB2IP ASXL1 UBE4B HIPK1 KIF1B IST1 NUP214 MADD PHF3 RIPOR1 CAMTA1 ARHGAP21 PDZD2 | 1.39e-07 | 407 | 172 | 13 | 12693553 | |
| Pubmed | IL12RB2 ERCC6 RNF31 ARHGAP23 TCOF1 NSD2 CHD8 PPFIA3 SRCAP KANK2 WDR26 BRWD3 SALL2 RPTOR CPEB4 FOXL2NB RAB11FIP5 IRS2 LZTS2 GARRE1 WWC1 | 1.75e-07 | 1116 | 172 | 21 | 31753913 | |
| Pubmed | 2.02e-07 | 225 | 172 | 10 | 12168954 | ||
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | FOXO3 SHROOM3 KIF1B CCDC85C IST1 NUP62 CORO1B FCHO2 KANK2 CEP164 MICALL1 RIMBP3 MAVS SYNJ1 NFKB1 DNMBP GARRE1 ARHGAP21 | 2.73e-07 | 853 | 172 | 18 | 28718761 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | FOXO3 EPS15 SHROOM3 UBE4B NSD2 KIF1B TM7SF3 HECTD4 CCDC85C ADGRG1 BRWD3 HIVEP3 ARHGAP6 TSC22D1 TBC1D22A SH3PXD2A RPTOR PRKAA2 RIPOR1 LZTS2 CAMTA1 SH3RF3 CRAMP1 PDZD2 | 3.67e-07 | 1489 | 172 | 24 | 28611215 |
| Pubmed | 4.74e-07 | 4 | 172 | 3 | 16081776 | ||
| Pubmed | RIM-BP3 is a manchette-associated protein essential for spermiogenesis. | 4.74e-07 | 4 | 172 | 3 | 19091768 | |
| Pubmed | 8.51e-07 | 103 | 172 | 7 | 10819331 | ||
| Pubmed | Activation of nuclear factor-kappaB p50 homodimer/Bcl-3 complexes in nasopharyngeal carcinoma. | 1.18e-06 | 5 | 172 | 3 | 14678988 | |
| Pubmed | Structure and evolution of RIM-BP genes: identification of a novel family member. | 1.18e-06 | 5 | 172 | 3 | 17855024 | |
| Pubmed | 1.18e-06 | 5 | 172 | 3 | 17641044 | ||
| Pubmed | Peering through the pore: nuclear pore complex structure, assembly, and function. | 1.23e-06 | 38 | 172 | 5 | 12791264 | |
| Pubmed | EPS15 CENPF UBR4 CCDC85C CHD8 NUP214 BIRC6 WDR26 SALL2 SYNJ1 IRS2 ARHGAP21 | 1.30e-06 | 418 | 172 | 12 | 34709266 | |
| Pubmed | DAB2IP HIPK1 PCLO BRSK2 SPECC1 SLC1A3 MADD SYNJ1 SH3PXD2A RPTOR RAB11FIP5 | 1.41e-06 | 347 | 172 | 11 | 17114649 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | METTL3 TCOF1 HIPK1 KIF1B NUP58 SRCAP RIMBP3 SALL2 SYNJ1 RPTOR RAB11FIP5 LZTS2 DNMBP GARRE1 | 1.53e-06 | 588 | 172 | 14 | 38580884 |
| Pubmed | Mucin gene expression in human laryngeal epithelia: effect of laryngopharyngeal reflux. | 1.67e-06 | 18 | 172 | 4 | 18834073 | |
| Pubmed | DAB2IP EPS15 ARHGAP23 APC2 PPFIA3 FCHO2 SPECC1 SLC1A3 RPTOR DNAJC11 ARHGAP21 PRPH | 1.75e-06 | 430 | 172 | 12 | 32581705 | |
| Pubmed | PODXL MKRN1 UBR4 RNF19B IST1 NUP62 MADD ANKRD13A SYNJ1 ZFP36L1 PHF3 NFKB1 RIMBP3C LZTS2 OTOG | 1.93e-06 | 689 | 172 | 15 | 36543142 | |
| Pubmed | EPS15 SHROOM3 RNF31 TENT4A UBR4 FCHO2 KANK2 BIRC6 MADD ANKRD13A PRKAA2 DNMBP SDC1 WWC1 | 2.10e-06 | 604 | 172 | 14 | 38803224 | |
| Pubmed | 2.35e-06 | 6 | 172 | 3 | 25086610 | ||
| Pubmed | Trophoblast giant cells express NF-kappa B2 during early mouse development. | 2.35e-06 | 6 | 172 | 3 | 10402669 | |
| Pubmed | RNF31 ARHGAP23 PODXL CDKN2AIP RIPOR3 CHD8 KANK2 SPECC1 WDR26 CNTROB TGIF1 TSC22D1 CELF2 ZFP36L1 SH3PXD2A RIPOR1 LZTS2 MRPL46 KLKB1 PSMG4 | 2.74e-06 | 1215 | 172 | 20 | 15146197 | |
| Pubmed | MKRN4P FOXO3 ZXDC SALL3 MKRN1 BCL3 SIX4 SRCAP ATAD2 HIVEP3 TGIF1 TSC22D1 SOX21 ZFP36L1 NFKB1 DMRT1 | 2.94e-06 | 808 | 172 | 16 | 20412781 | |
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | SMG1 EPS15 ARHGAP23 BRSK2 KANK2 SPECC1 WDR26 CCNT2 BRAF SH3PXD2A PRKAA2 MAP3K9 BOP1 LZTS2 BRSK1 MAP3K21 ARHGAP21 | 3.09e-06 | 910 | 172 | 17 | 36736316 |
| Pubmed | 5.68e-06 | 24 | 172 | 4 | 32212159 | ||
| Pubmed | SHANK1 TCOF1 UBE4B HIPK1 KIF1B UBR4 APC2 HECTD4 IST1 RIPK4 NUP58 KANK2 SPECC1 WDR26 BRWD3 MADD GORASP2 SYNJ1 TNKS2 ARHGAP21 | 6.29e-06 | 1285 | 172 | 20 | 35914814 | |
| Pubmed | A census of human transcription factors: function, expression and evolution. | FOXO3 NSD2 RELB SIX4 GMEB2 HIVEP3 TGIF1 TSC22D1 SALL2 SOX21 ZFP36L1 NFKB1 CAMTA1 DMRT1 MYRF CRAMP1 | 1.26e-05 | 908 | 172 | 16 | 19274049 |
| Pubmed | The TRAF2-p62 axis promotes proliferation and survival of liver cancer by activating mTORC1 pathway. | 1.39e-05 | 10 | 172 | 3 | 37081115 | |
| Pubmed | Integrated structural analysis of the human nuclear pore complex scaffold. | 1.43e-05 | 30 | 172 | 4 | 24315095 | |
| Pubmed | 1.43e-05 | 30 | 172 | 4 | 27016207 | ||
| Pubmed | DAB2IP SHANK1 UBAP2 IARS1 PCLO UBR4 NACA BRSK2 CORO1B PPFIA3 BIRC6 WDR26 SLC1A3 MADD SYNJ1 RPTOR DNAJC11 CPEB4 | 1.54e-05 | 1139 | 172 | 18 | 36417873 | |
| Pubmed | Genome-wide association study of periodontal pathogen colonization. | 1.64e-05 | 31 | 172 | 4 | 22699663 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | EPS15 UBAP2 TCOF1 CDKN2AIP NACA CCDC85C IST1 NUP62 NUP214 CORO1B SRCAP GORASP2 MAVS SYNJ1 IRS2 ARHGAP21 | 1.78e-05 | 934 | 172 | 16 | 33916271 |
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 17963943 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 12964007 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 24680660 | ||
| Pubmed | NF-kB and Bcl-3 activation are prognostic in metastatic colorectal cancer. | 2.43e-05 | 2 | 172 | 2 | 20414006 | |
| Pubmed | Allelic variants of CAMTA1 and FLJ10737 within a commonly deleted region at 1p36 in neuroblastoma. | 2.43e-05 | 2 | 172 | 2 | 17222547 | |
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 29562502 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 30143610 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 22558357 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 35108347 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 34801967 | ||
| Pubmed | Negative regulation of toll-like receptor signaling by NF-kappaB p50 ubiquitination blockade. | 2.43e-05 | 2 | 172 | 2 | 17673665 | |
| Pubmed | PKK deletion in basal keratinocytes promotes tumorigenesis after chemical carcinogenesis. | 2.43e-05 | 2 | 172 | 2 | 29186361 | |
| Pubmed | Role of Rel/NF-kappaB transcription factors in apoptosis of human hepatocellular carcinoma cells. | 2.43e-05 | 2 | 172 | 2 | 12365017 | |
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 21697367 | ||
| Pubmed | Silencing METTL3 inhibits the proliferation and invasion of osteosarcoma by regulating ATAD2. | 2.43e-05 | 2 | 172 | 2 | 32044716 | |
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 23544943 | ||
| Pubmed | RelB, a new Rel family transcription activator that can interact with p50-NF-kappa B. | 2.43e-05 | 2 | 172 | 2 | 1732739 | |
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 14690056 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 26918940 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 9104822 | ||
| Pubmed | The antiviral adaptor proteins Cardif and Trif are processed and inactivated by caspases. | 2.43e-05 | 2 | 172 | 2 | 18756281 | |
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 18178804 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 21249144 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 16415359 | ||
| Pubmed | Isozyme-Specific Role of SAD-A in Neuronal Migration During Development of Cerebral Cortex. | 2.43e-05 | 2 | 172 | 2 | 30307479 | |
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 16835236 | ||
| Pubmed | BCL3 encodes a nuclear protein which can alter the subcellular location of NF-kappa B proteins. | 2.43e-05 | 2 | 172 | 2 | 8196632 | |
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 25113400 | ||
| Pubmed | eEF1Bγ is a positive regulator of NF-кB signaling pathway. | 2.43e-05 | 2 | 172 | 2 | 24613846 | |
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 34155197 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 7834753 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 18796561 | ||
| Pubmed | An expressed pseudogene regulates the messenger-RNA stability of its homologous coding gene. | 2.43e-05 | 2 | 172 | 2 | 12721631 | |
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 25115498 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 16123212 | ||
| Pubmed | Disruption of either the Nfkb1 or the Bcl3 gene inhibits skeletal muscle atrophy. | 2.43e-05 | 2 | 172 | 2 | 15546001 | |
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 25922067 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 1501714 | ||
| Pubmed | Airway epithelial NF-κB activation promotes allergic sensitization to an innocuous inhaled antigen. | 2.43e-05 | 2 | 172 | 2 | 20581095 | |
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 16630837 | ||
| Pubmed | [Effect of RelB on HIV-1 Vpr-mediated transcription activation and cell G2/M arrest]. | 2.43e-05 | 2 | 172 | 2 | 23547379 | |
| Pubmed | Genetic association of CUGBP2 and DNMBP with Alzheimer' s disease in the Chinese Han population. | 2.43e-05 | 2 | 172 | 2 | 25801238 | |
| Pubmed | Identification of Makorin 1 as a novel SEREX antigen of esophageal squamous cell carcinoma. | 2.43e-05 | 2 | 172 | 2 | 19604354 | |
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 16882727 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 21933986 | ||
| Pubmed | Significance of serum tumor marker levels in peritoneal carcinomatosis of appendiceal origin. | 2.43e-05 | 2 | 172 | 2 | 22941175 | |
| Pubmed | Canine hepacivirus NS3 serine protease can cleave the human adaptor proteins MAVS and TRIF. | 2.43e-05 | 2 | 172 | 2 | 22870331 | |
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 24192491 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 33691755 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 17039240 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 18596915 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 35354439 | ||
| Pubmed | The NF-κB RelB protein is an oncogenic driver of mesenchymal glioma. | 2.43e-05 | 2 | 172 | 2 | 23451236 | |
| Pubmed | Both multiorgan inflammation and myeloid hyperplasia in RelB-deficient mice are T cell dependent. | 2.43e-05 | 2 | 172 | 2 | 8892630 | |
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 22645312 | ||
| Interaction | YWHAH interactions | DAB2IP FOXO3 SHROOM3 UBAP2 PARP8 KIF1B HECTD4 CCDC85C NUP62 RIPK4 SPECC1 WDR26 MADD MICALL1 VPS13D BRAF SYNJ1 ZFP36L1 SH3PXD2A PHF3 RPTOR PRKAA2 MAP3K9 RAB11FIP5 IRS2 MAP3K21 DNMBP SH3RF3 GARRE1 ARHGAP21 WWC1 OTOG | 4.46e-10 | 1102 | 167 | 32 | int:YWHAH |
| Interaction | YWHAG interactions | DAB2IP FOXO3 SHROOM3 UBAP2 RNF31 ARHGAP23 PARP8 KIF1B HECTD4 CCDC85C NUP62 RIPK4 SPECC1 MICALL1 VPS13D TTBK1 BRAF SYNJ1 ZFP36L1 SH3PXD2A PHF3 RPTOR MAP3K9 RAB11FIP5 IRS2 LZTS2 MAP3K21 DNMBP SH3RF3 GARRE1 ARHGAP21 WWC1 OTOG | 2.43e-09 | 1248 | 167 | 33 | int:YWHAG |
| Interaction | TOP3B interactions | DAB2IP FOXO3 ZXDC SHROOM3 UBAP2 UBE4B SZT2 CENPF NSD2 IARS1 KIF1B UBR4 HECTD4 CHD8 RELB NUP214 CORO1B SRCAP KANK2 BIRC6 CNTROB MADD MICALL1 HIVEP3 GORASP2 HEG1 SYNJ1 RPTOR CPEB4 RIPOR1 IRS2 MRPL46 DNMBP MYRF ARHGAP21 CRAMP1 | 3.07e-09 | 1470 | 167 | 36 | int:TOP3B |
| Interaction | YWHAB interactions | DAB2IP FOXO3 SHROOM3 ARHGAP23 PARP8 KIF1B HECTD4 CCDC85C RIPK4 SPECC1 MICALL1 VPS13D BRAF ZFP36L1 TBC1D22A SH3PXD2A PHF3 PRKAA2 MAP3K9 RAB11FIP5 IRS2 MAP3K21 DNMBP SH3RF3 GARRE1 ARHGAP21 WWC1 OTOG | 1.91e-08 | 1014 | 167 | 28 | int:YWHAB |
| Interaction | YWHAZ interactions | DAB2IP FOXO3 ASXL1 SHROOM3 PARP8 KIF1B HECTD4 CCDC85C RIPK4 PPFIA3 KANK2 SPECC1 SLC1A3 MADD MICALL1 VPS13D BRAF ZFP36L1 SH3PXD2A PHF3 RPTOR PRKAA2 MAP3K9 RAB11FIP5 IRS2 MAP3K21 DNMBP GARRE1 ARHGAP21 OTOG | 3.96e-07 | 1319 | 167 | 30 | int:YWHAZ |
| Interaction | PHF21A interactions | EPS15 CENPF UBR4 CCDC85C CHD8 NUP62 NUP214 NUP58 BIRC6 WDR26 SALL2 SYNJ1 IRS2 ARHGAP21 | 1.08e-06 | 343 | 167 | 14 | int:PHF21A |
| Interaction | GIGYF1 interactions | KIF1B CNTROB SH3PXD2A RPTOR CPEB4 PRKAA2 LZTS2 MAP3K21 SH3RF3 GARRE1 | 2.28e-06 | 177 | 167 | 10 | int:GIGYF1 |
| Interaction | YWHAE interactions | DAB2IP FOXO3 SHROOM3 RNF31 PARP8 KIF1B BRSK2 CCDC85C RIPK4 KANK2 SPECC1 MICALL1 BRAF ZFP36L1 SH3PXD2A RPTOR MAP3K9 RAB11FIP5 IRS2 BRSK1 MAP3K21 DNMBP SH3RF3 GARRE1 ARHGAP21 WWC1 OTOG | 4.74e-06 | 1256 | 167 | 27 | int:YWHAE |
| Interaction | KSR1 interactions | 1.45e-05 | 132 | 167 | 8 | int:KSR1 | |
| Interaction | YWHAQ interactions | DAB2IP FOXO3 SHROOM3 UBAP2 ARHGAP23 PARP8 KIF1B HECTD4 RIPK4 SPECC1 VPS13D BRAF ZFP36L1 SH3PXD2A RPTOR NFKB1 MAP3K9 IRS2 MAP3K21 DNMBP GARRE1 ARHGAP21 WWC1 OTOG | 1.75e-05 | 1118 | 167 | 24 | int:YWHAQ |
| Interaction | CBY1 interactions | DAB2IP FOXO3 KIF1B MICALL1 GORASP2 SH3PXD2A RPTOR MAP3K21 SH3RF3 | 2.16e-05 | 182 | 167 | 9 | int:CBY1 |
| Interaction | VASP interactions | EPS15 SHROOM3 UBR4 CCDC85C KANK2 SYNJ1 RAB11FIP5 IRS2 LZTS2 DNMBP ARHGAP21 | 3.56e-05 | 294 | 167 | 11 | int:VASP |
| Interaction | CGN interactions | 4.01e-05 | 152 | 167 | 8 | int:CGN | |
| Interaction | FOXL2NB interactions | 6.83e-05 | 2 | 167 | 2 | int:FOXL2NB | |
| Interaction | MAPRE1 interactions | EPS15 ERCC6 KIF1B APC2 NUP62 NUP214 NUP58 BCL3 SPECC1 TTBK1 MAVS DNMBP POM121B ARHGAP21 | 1.01e-04 | 514 | 167 | 14 | int:MAPRE1 |
| Interaction | MAST3 interactions | 1.01e-04 | 129 | 167 | 7 | int:MAST3 | |
| Interaction | KCNA3 interactions | EPS15 TCOF1 SZT2 IARS1 KIF1B NACA NUP214 CORO1B FCHO2 SPECC1 MICALL1 PHF3 RPTOR RAB11FIP5 IRS2 POLQ MAP3K21 ARHGAP21 OTOG | 1.15e-04 | 871 | 167 | 19 | int:KCNA3 |
| GeneFamily | CD molecules|Mucins | 1.31e-07 | 21 | 108 | 5 | 648 | |
| GeneFamily | PDZ domain containing | 3.54e-05 | 152 | 108 | 7 | 1220 | |
| GeneFamily | Nucleoporins | 3.81e-05 | 32 | 108 | 4 | 1051 | |
| GeneFamily | Ankyrin repeat domain containing|NF-kappa B complex subunits | 3.49e-04 | 5 | 108 | 2 | 1254 | |
| GeneFamily | Mitogen-activated protein kinase kinase kinases|RAF family | 3.83e-04 | 24 | 108 | 3 | 654 | |
| GeneFamily | Ankyrin repeat domain containing | 6.25e-04 | 242 | 108 | 7 | 403 | |
| GeneFamily | Ring finger proteins | 1.32e-03 | 275 | 108 | 7 | 58 | |
| GeneFamily | Sterile alpha motif domain containing | 1.91e-03 | 88 | 108 | 4 | 760 | |
| GeneFamily | Rho GTPase activating proteins|BCH domain containing | 3.31e-03 | 50 | 108 | 3 | 721 | |
| GeneFamily | Zinc fingers|Zinc fingers PARP-type|Poly(ADP-ribose) polymerases | 4.53e-03 | 17 | 108 | 2 | 684 | |
| Coexpression | GSE41978_ID2_KO_AND_BIM_KO_VS_BIM_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_DN | 7.51e-07 | 199 | 170 | 10 | M9567 | |
| Coexpression | DAZARD_RESPONSE_TO_UV_SCC_DN | 8.71e-07 | 115 | 170 | 8 | M7484 | |
| Coexpression | KOINUMA_TARGETS_OF_SMAD2_OR_SMAD3 | DAB2IP FOXO3 SMG1 PARP8 IST1 ADGRG1 RIPK4 FCHO2 ATAD2 SPECC1 SLC1A3 MICALL1 TGIF1 TSC22D1 ZFP36L1 SH3PXD2A NFKB1 ARHGAP21 WWC1 | 2.58e-06 | 843 | 170 | 19 | M2356 |
| Coexpression | GSE45881_CXCR6HI_VS_CXCR1LO_COLONIC_LAMINA_PROPRIA_UP | 6.70e-06 | 200 | 170 | 9 | M9889 | |
| Coexpression | BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP | FOXO3 BAZ2B CDKN2AIP TICAM1 MKRN1 RNF19B IST1 RELB NUP58 GMEB2 CCNT2 TSC22D1 PHF3 MAP3K9 RIPOR1 IRS2 GARRE1 PDZD2 | 7.14e-06 | 822 | 170 | 18 | M6782 |
| Coexpression | KRIEG_HYPOXIA_NOT_VIA_KDM3A | DAB2IP ASXL1 TENT4A CENPF PPFIA4 TICAM1 MKRN1 CCDC85C RIPK4 ATAD2 VPS13D PRKAA2 RAB11FIP5 IRS2 MAP3K21 SDC1 CRAMP1 | 7.77e-06 | 746 | 170 | 17 | M2469 |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | MKRN4P ARHGAP23 COL20A1 BAZ2B NSD2 KIF1B MKRN1 TM7SF3 HECTD4 SRCAP SPECC1 SLC1A3 CCNT2 TSC22D1 TTBK1 SOX21 TBC1D22A SRPK3 BRSK1 MYRF SDC1 | 1.35e-05 | 1124 | 170 | 21 | MM1070 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C3_DEFINITIVE_ERYTHROBLAST | 1.64e-05 | 24 | 170 | 4 | M45748 | |
| Coexpression | GSE35825_UNTREATED_VS_IFNG_STIM_MACROPHAGE_DN | 2.50e-05 | 181 | 170 | 8 | M8662 | |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | ARHGAP23 COL20A1 BAZ2B NSD2 KIF1B MKRN1 TM7SF3 HECTD4 SRCAP SPECC1 SLC1A3 CCNT2 TSC22D1 TTBK1 SOX21 TBC1D22A SRPK3 BRSK1 MYRF SDC1 | 3.31e-05 | 1102 | 170 | 20 | M2369 |
| Coexpression | GSE2770_TGFB_AND_IL4_VS_IL12_TREATED_ACT_CD4_TCELL_48H_DN | 4.92e-05 | 199 | 170 | 8 | M6108 | |
| Coexpression | GSE45739_UNSTIM_VS_ACD3_ACD28_STIM_NRAS_KO_CD4_TCELL_UP | 5.09e-05 | 200 | 170 | 8 | M9883 | |
| Coexpression | GSE37533_UNTREATED_VS_PIOGLIZATONE_TREATED_CD4_TCELL_PPARG1_AND_FOXP3_TRASDUCED_DN | 5.09e-05 | 200 | 170 | 8 | M9002 | |
| Coexpression | GILMORE_CORE_NFKB_PATHWAY | 7.31e-05 | 13 | 170 | 3 | M8804 | |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_DN | NSD2 ADGRG1 RIPK4 CORO1B SRCAP VWA7 ATAD2 ARHGAP6 HEG1 PHF3 CHFR MAP3K9 BOP1 CACNA1I MUC4 TNXB SDC1 | 9.29e-05 | 909 | 170 | 17 | M41018 |
| Coexpression | MCBRYAN_PUBERTAL_BREAST_4_5WK_UP | 1.05e-04 | 284 | 170 | 9 | MM987 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_k-means-cluster#3_top-relative-expression-ranked_1000 | SMG1 NUP214 NUP58 SIX4 BIRC6 CCNT2 PHF3 RPTOR CPEB4 TNKS2 DNMBP GARRE1 WWC1 | 9.99e-06 | 379 | 167 | 13 | gudmap_developingKidney_e15.5_1000_k3 |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | SMG1 BAZ2B NSD2 MUC16 PLEKHS1 MUC5B SH3PXD2A PRKAA2 MUC4 ARHGAP21 | 2.00e-09 | 179 | 171 | 10 | 6e965e424eebef50f0202cff75f458be395cfca1 |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage-Monocyte-derived_macrophage_L.1.2.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.14e-08 | 184 | 171 | 9 | 857ca1fc4de07b300839b22924211dc624453841 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | AHI1-DT SHROOM3 PCLO ADGRG1 ARHGAP6 CPEB4 PRKAA2 MAP3K21 WWC1 | 6.52e-08 | 194 | 171 | 9 | 5eaaa81f4b2535f983c424aaef00077089526a5c |
| ToppCell | wk_20-22-Hematologic-Meg-ery-Definitive_erythroblast|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 5.38e-07 | 182 | 171 | 8 | 0c77ef4556c1d1512ebe9077df858b28f9e38dd5 | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)-hematologic-erythrocytic-erythrocyte|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 8.38e-07 | 193 | 171 | 8 | 305e15ee467826ee08b2617c69f250ad39c11b19 | |
| ToppCell | Club_cells-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 8.38e-07 | 193 | 171 | 8 | 6582c0367052b9d10fb629c383ee0c55872afd2d | |
| ToppCell | Club_cells|World / lung cells shred on cell class, cell subclass, sample id | 8.38e-07 | 193 | 171 | 8 | 9d3165dc5763a07a7d873f497624d9d6528fa2db | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)-hematologic-erythrocytic|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 8.38e-07 | 193 | 171 | 8 | dd376664906caccc9c2065f8e7a364509e18a5cc | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.42e-07 | 196 | 171 | 8 | 6ce74aa3f0ce3ca284b67e5a4660ffd2cc9611e0 | |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia-tRG|World / Primary Cells by Cluster | 9.78e-07 | 197 | 171 | 8 | 61749ccafeb938c310cff1de5ff924a1c794325a | |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia-tRG-25|World / Primary Cells by Cluster | 9.78e-07 | 197 | 171 | 8 | 9d4ffa3680f92c91d0a081f9a8ec5ebfec6bdcf6 | |
| ToppCell | COPD-Myeloid-Macrophage|Myeloid / Disease state, Lineage and Cell class | 1.06e-06 | 199 | 171 | 8 | 1cf1b2d6debf9e3389f1829dcaa2857e9533a080 | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_secretory|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.06e-06 | 199 | 171 | 8 | 7223f853335492ca617dbec3e4b6872a8a463a45 | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_secretory-Secretory_Goblet|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.06e-06 | 199 | 171 | 8 | e03bdc7cb825e287f41b834ec6061d23c1c03b04 | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_Tubular|TCGA-Stomach / Sample_Type by Project: Shred V9 | 1.08e-06 | 138 | 171 | 7 | 93497c0a5d5e54006653b2dedc7a7041e1a613e6 | |
| ToppCell | LPS_IL1RA_TNF-Hematopoietic_Erythro-Megakary-Erythro-Mega-Erythroid|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.10e-06 | 200 | 171 | 8 | f100edfd2b3b742458cbbf34de9c403c4d272d3c | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.78e-06 | 159 | 171 | 7 | 60b1f4dce2ce0911160fda17f137c064da31e2eb | |
| ToppCell | facs-Lung-EPCAM-3m-Epithelial-Basal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.02e-06 | 183 | 171 | 7 | ecac1cfaff7553a60305b34d6cede6973ffb5430 | |
| ToppCell | facs-Lung-EPCAM-3m-Epithelial-respiratory_basal_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.02e-06 | 183 | 171 | 7 | f6ebfd7f61e912f92bd07313cc213a171747ac03 | |
| ToppCell | Monocytes-M2-like_CD16+_macrophages|Monocytes / Immune cells in Kidney/Urine in Lupus Nephritis | 8.08e-06 | 187 | 171 | 7 | 59e31c51183ed4c9a3d0792c8005ea3a12b28dfa | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.36e-06 | 188 | 171 | 7 | 43a3a59f92ad93509d4166bd025aed0b1b39a008 | |
| ToppCell | Severe_COVID-19-Epithelial-undefined_Epi|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 8.66e-06 | 189 | 171 | 7 | 8cbd35320c7e7ff013ef0c0f13f8d875db1c53cd | |
| ToppCell | Control-Myeloid-TRAM2|Myeloid / Condition, Lineage and Cell class | 9.59e-06 | 192 | 171 | 7 | 571fd71dad361a8b6c1bf9ad7184a89b3fbec667 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.59e-06 | 192 | 171 | 7 | 2510f22197502f60fd266b7f42eff040f25b8ae7 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.59e-06 | 192 | 171 | 7 | e8e316f396834bcd34843e56e1d86f310fd6aada | |
| ToppCell | cellseq-Epithelial-Epithelial_Glandular-Goblet|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.92e-06 | 193 | 171 | 7 | 71bf8fb5314b79cb30f4eb9c8459b21f10cd6d35 | |
| ToppCell | cellseq-Epithelial-Epithelial_Glandular-Goblet-Goblet|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.92e-06 | 193 | 171 | 7 | b05e110b13d35d34294357c8e1c4fd23bf4b6c92 | |
| ToppCell | wk_08-11-Hematologic-Meg-ery-Definitive_erythroblast|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 9.92e-06 | 193 | 171 | 7 | be75abfdf5301cf33df8ee9ed92504d44fdf19a6 | |
| ToppCell | COPD-Myeloid-Macrophage|World / Disease state, Lineage and Cell class | 1.03e-05 | 194 | 171 | 7 | 7d682408e9a6239a4e47befc9376e760cc3d133a | |
| ToppCell | Control-Myeloid-TRAM2|Control / Condition, Lineage and Cell class | 1.03e-05 | 194 | 171 | 7 | d951dd1274d3ff1ac30671ec4153a4a8bc97b53f | |
| ToppCell | Epithelial_cells-Club_cells|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id | 1.06e-05 | 195 | 171 | 7 | b758676abfc4e6930b696d270ecc0ea461b87a54 | |
| ToppCell | NS-critical-LOC-Epithelial-Secretory|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.06e-05 | 195 | 171 | 7 | b0d782eeee30c797b4da9b3be29b864983fd9e71 | |
| ToppCell | 3'_v3-blood-Lymphocytic_NK-NK_CD56bright_CD16-|blood / Manually curated celltypes from each tissue | 1.06e-05 | 195 | 171 | 7 | 1470f562ebcfe7da367964ecfd6c7f43bcdb4a73 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.10e-05 | 196 | 171 | 7 | a52879a4c822c5e4be569f01f845a795e00c5f4b | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.10e-05 | 196 | 171 | 7 | 7a4d502550e9e37dc42f2ff1be3c896afe365d7f | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.10e-05 | 196 | 171 | 7 | 60ea673ed887fe3890c5cf4ff4165384b76d7361 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-6_mon-Macroglial|6_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.13e-05 | 197 | 171 | 7 | 965d5a3f8c9b12cb8a8d3429702ae29ebd8c6122 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-6_mon-Macroglial-Astroglia|6_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.13e-05 | 197 | 171 | 7 | 3f088eb29197bc575400d6dafd8083e69e4a149f | |
| ToppCell | Control_saline-Hematopoietic_Erythro-Megakary-Erythro-Mega|Control_saline / Treatment groups by lineage, cell group, cell type | 1.17e-05 | 198 | 171 | 7 | 1a39a98beef68e1e6d3adc25270a3336fcc5baf4 | |
| ToppCell | Control_saline-Hematopoietic_Erythro-Megakary-Erythro-Mega-Erythroid|Control_saline / Treatment groups by lineage, cell group, cell type | 1.17e-05 | 198 | 171 | 7 | dd80fd9671ee863aebcf4c1023d3e004cc2ee709 | |
| ToppCell | proximal-3-Epithelial-Goblet|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.17e-05 | 198 | 171 | 7 | 3477202c4f702d8f75231b13d4b5216f56d981d7 | |
| ToppCell | proximal-Epithelial-Goblet|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.17e-05 | 198 | 171 | 7 | e7e1c430486a81280abc4a7e7f5bc3713dd20737 | |
| ToppCell | Control_saline-Hematopoietic_Erythro-Megakary|Control_saline / Treatment groups by lineage, cell group, cell type | 1.17e-05 | 198 | 171 | 7 | cfc2a860bae883299987d3e374d0476ca20e1bdd | |
| ToppCell | proximal-Epithelial-Goblet-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.17e-05 | 198 | 171 | 7 | da7b40eb00bb5e454e1cfcd1219dc0d84712592a | |
| ToppCell | LPS_anti-TNF-Hematopoietic_Erythro-Megakary-Erythro-Mega-Erythroid|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.21e-05 | 199 | 171 | 7 | 565404c155dfac57c020a8f2d09cbf756da20ffd | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_secretory|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.21e-05 | 199 | 171 | 7 | 70c0b9cff195d3d24e98443a729e211cac20c90f | |
| ToppCell | LPS_IL1RA_TNF-Hematopoietic_Erythro-Megakary|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.21e-05 | 199 | 171 | 7 | f894c88ecc7fd0edca28587801fa59352d10f750 | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_secretory-Secretory_Goblet|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.21e-05 | 199 | 171 | 7 | ec1e110671e7725f752163c7241dbbf638dec2b2 | |
| ToppCell | LPS_anti-TNF-Hematopoietic_Erythro-Megakary|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.21e-05 | 199 | 171 | 7 | 6c174dbcc25b980f10a3d1dfe39e613acac73bb6 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_secretory-Secretory_Goblet|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.21e-05 | 199 | 171 | 7 | 3c3133d0aa65338a576634def13e7f0f5c573a10 | |
| ToppCell | LPS_anti-TNF-Hematopoietic_Erythro-Megakary-Erythro-Mega|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.21e-05 | 199 | 171 | 7 | 284ee9632413f6404fc0b0c7c393ad813db834f2 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_hypoxia-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.21e-05 | 199 | 171 | 7 | 379bbd9cecf466b902411c54d74bd9885285b1ba | |
| ToppCell | Frontal_cortex-Neuronal|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.21e-05 | 199 | 171 | 7 | f88039d862f3bfa01dc39d2de4f3f548dc5a0e61 | |
| ToppCell | LPS_IL1RA_TNF-Hematopoietic_Erythro-Megakary-Erythro-Mega|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.21e-05 | 199 | 171 | 7 | 2b754670fe77c2301afcdcfc73a1e52cc0cd1de3 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_secretory|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.21e-05 | 199 | 171 | 7 | a706ad5cd5e0dc8d7e925a05e45b07d35963f294 | |
| ToppCell | Bronchial-10x5prime-Epithelial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.25e-05 | 200 | 171 | 7 | d3ee5f79513e2ac02ad3329b59e6290d457c44d2 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW10-Macroglial-Astrocyte|GW10 / Sample Type, Dataset, Time_group, and Cell type. | 1.25e-05 | 200 | 171 | 7 | 98a994692440cb4f505b050276f0c8022c814a21 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW10-Macroglial|GW10 / Sample Type, Dataset, Time_group, and Cell type. | 1.25e-05 | 200 | 171 | 7 | ef222dc4a205d670172dae74990bdb952ac92e5b | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW23-Macroglial|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 1.25e-05 | 200 | 171 | 7 | 70c2e577efb6b6fe8f9d970d7ecc470788efb85b | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_basal-Suprabasal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.25e-05 | 200 | 171 | 7 | ce969c958a31145bbfe315a9a865d7900ecc9549 | |
| ToppCell | AT1-AT2_cells-Donor_08|World / lung cells shred on cell class, cell subclass, sample id | 2.07e-05 | 145 | 171 | 6 | cd5de30fd948024e3ad043c9411ce9f2722178b2 | |
| ToppCell | E15.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.91e-05 | 154 | 171 | 6 | e65e4636646164610f33f7bbac0d879a3ea55986 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5|TCGA-Ovary / Sample_Type by Project: Shred V9 | 4.43e-05 | 166 | 171 | 6 | 32d2eaf8a5d03881bf74d680825af2d5110b082d | |
| ToppCell | Club_cells-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 4.58e-05 | 167 | 171 | 6 | dbdaaeb3bd9139cb008d9fe24ec031fc5628f136 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.90e-05 | 169 | 171 | 6 | b253a4a50c06d36228fcd5d856c57202cbac158f | |
| ToppCell | tumor_Lymph_Node_/_Brain-T/NK_cells-Exhausted_Tfh|T/NK_cells / Location, Cell class and cell subclass | 4.90e-05 | 169 | 171 | 6 | 625788d86f0ceebcf2653a251db1f1a9f9746d29 | |
| ToppCell | NS-critical-d_0-4-Epithelial-Secretory|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.90e-05 | 169 | 171 | 6 | aec97583b23112060437b619cb429dc32f29285f | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Epithelial-neuro-epithelial-L_cells_(PYY+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.06e-05 | 170 | 171 | 6 | 6a98f47f8c2b5b15e09169bd82eff1e6bf76e5a6 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.58e-05 | 173 | 171 | 6 | 4bc6d93716f093b460c8b047199db8cab5fea720 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.58e-05 | 173 | 171 | 6 | 464267a2ff3f5c387b6c9c6fa4dab135a221f448 | |
| ToppCell | AT1_cells-Donor_07|World / lung cells shred on cell class, cell subclass, sample id | 5.58e-05 | 173 | 171 | 6 | b29816427428c7053017477f59b828bf1357f3b2 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.76e-05 | 174 | 171 | 6 | 207aa0118633cbe9a65839bbb1bb3ba9f8118ad2 | |
| ToppCell | 5'-Adult-Distal_Rectal-Epithelial-goblet-BEST2+_Goblet_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.94e-05 | 175 | 171 | 6 | 019ea30ac55748463d7917abf3d3f0e804189bfd | |
| ToppCell | facs-Lung-3m-Epithelial-airway_epithelial-respiratory_basal_cell-basal_epithelial_cell_of_bronchioalveolar_tree|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.53e-05 | 178 | 171 | 6 | b89c4d015b44bf538aa39969ef8778877c8023f1 | |
| ToppCell | 5'-Adult-Distal_Rectal-Epithelial-goblet|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.53e-05 | 178 | 171 | 6 | 9099b47e0756d6a1b7ba1c6aa7b47c5425f649e0 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.53e-05 | 178 | 171 | 6 | a74e5a390cbeaca9de1fdb7b2a0e50783bd202dd | |
| ToppCell | facs-Lung-3m-Epithelial-airway_epithelial-respiratory_basal_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.53e-05 | 178 | 171 | 6 | fb8f8d95f6b08378fb42c4076ee040276faa296f | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.53e-05 | 178 | 171 | 6 | 1bddbc083c36657bd6910f7466126ab325e88176 | |
| ToppCell | droplet-Thymus-nan-24m-Lymphocytic-DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.16e-05 | 181 | 171 | 6 | 3fe648db1cb8326066d8bde3ca1287c5c9af19bd | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.16e-05 | 181 | 171 | 6 | 576da14ab3107f89e1f44a4a439d1bef5bb42370 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.16e-05 | 181 | 171 | 6 | e0abf2707d9e0aa942c657eef7d2cbcd02f060dd | |
| ToppCell | PND14-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.38e-05 | 182 | 171 | 6 | 21dcab170ffeef89faa9fee5008568cb6e15c694 | |
| ToppCell | HSPCs-LMPPs|World / Lineage and Cell class | 7.61e-05 | 183 | 171 | 6 | e401f06843528a75693ce455bbeff2a98b8c24e5 | |
| ToppCell | Fetal_29-31_weeks-Immune-enucleated_erythrocyte-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.08e-05 | 185 | 171 | 6 | e8f7da9641b6cf1db1093b4f301ce828fd3a529c | |
| ToppCell | LPS_only|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.08e-05 | 185 | 171 | 6 | a72ccb147ca505880e2da8f6a70b9d570464a691 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.08e-05 | 185 | 171 | 6 | eb7d3c1363d5fedc611f9c1a91ea823de251355e | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-lymphocytic-innate_lymphocytic|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 8.32e-05 | 186 | 171 | 6 | fc0b488c201a32d829047b58460297df2818b45d | |
| ToppCell | COPD-Epithelial-Goblet|World / Disease state, Lineage and Cell class | 8.32e-05 | 186 | 171 | 6 | d75fe7640a4b2c450c9759a1b3c3ef2a087f0092 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 8.32e-05 | 186 | 171 | 6 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_proliferating-epi_proliferating1_(8)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 8.57e-05 | 187 | 171 | 6 | c2940aec30b3c2c113f6a65126dc6f1969cf301e | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-lymphocytic-innate_lymphocytic-mature_NK_T_cell|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 8.57e-05 | 187 | 171 | 6 | 6981b856187a2e689260ecb7d0a1193a374ee9b9 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 8.82e-05 | 188 | 171 | 6 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.82e-05 | 188 | 171 | 6 | bc089cd73d283ed7d2ecbb3936673b4edc89f666 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.82e-05 | 188 | 171 | 6 | eec3d353e51358db4c7621265ee0fdd4298e5b0e | |
| ToppCell | wk_08-11-Epithelial-Proximal_epithelial-Proximal_secretory_2|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 8.82e-05 | 188 | 171 | 6 | 07705bed928683470a52c8ccfa40ffb9a0971318 | |
| ToppCell | PCW_10-12-Endothelial-Endothelial_mature-endo_bronchial_(8)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 9.09e-05 | 189 | 171 | 6 | 033a2be8bbb7bfb437e6f1657b6ca02070c74aa8 | |
| ToppCell | facs-Lung-18m-Epithelial-airway_epithelial-respiratory_basal_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.35e-05 | 190 | 171 | 6 | 47e07ea22733306d8885ee9e5f0b033e2f5e2afb | |
| ToppCell | facs-Lung-18m-Epithelial-airway_epithelial-respiratory_basal_cell-basal_epithelial_cell_of_bronchioalveolar_tree|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.35e-05 | 190 | 171 | 6 | 261b8afddfdcba4f70b50df126cef7ad00a0aae0 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.35e-05 | 190 | 171 | 6 | 6ea9fa08bd97bedcb21d3654467e7f8dd74c8fd0 | |
| ToppCell | IPF-Epithelial-Goblet|IPF / Disease state, Lineage and Cell class | 9.35e-05 | 190 | 171 | 6 | e41dd5a997ad9952810ffecb57737c03ea1d88b3 | |
| Drug | Cycloheximide [66-81-9]; Up 200; 14.2uM; MCF7; HT_HG-U133A | ZXDC CDKN2AIP PCLO RNF19B HECTD4 RELB PPFIA3 SRCAP HEG1 SYNJ1 IRS2 | 8.08e-08 | 178 | 166 | 11 | 6220_UP |
| Drug | Ganciclovir [82410-32-0]; Down 200; 15.6uM; PC3; HT_HG-U133A | CENPF CCDC85C GMEB2 SLC1A3 BRAF TBC1D22A GLE1 PHF3 TNKS2 PRPH | 1.93e-06 | 197 | 166 | 10 | 6289_DN |
| Drug | Tenoxicam [59804-37-4]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 1.32e-05 | 194 | 166 | 9 | 4182_UP | |
| Drug | chlorpromazine hydrochloride; Down 200; 1uM; PC3; HT_HG-U133A | 1.32e-05 | 194 | 166 | 9 | 1217_DN | |
| Drug | Metoprolol-(+,-) (+)-tartrate salt [56392-17-7]; Down 200; 5.8uM; MCF7; HT_HG-U133A | 1.49e-05 | 197 | 166 | 9 | 6106_DN | |
| Drug | Levopropoxyphene napsylate [5714-90-9]; Up 200; 7.4uM; PC3; HT_HG-U133A | SHANK1 CEACAM5 IL37 PPFIA4 BRSK2 GABRQ HIVEP3 SOX21 TBC1D22A | 1.49e-05 | 197 | 166 | 9 | 5083_UP |
| Drug | U-62066 [87151-85-7]; Down 200; 1uM; PC3; HT_HG-U133A | 1.49e-05 | 197 | 166 | 9 | 4553_DN | |
| Drug | Minoxidil [38304-91-5]; Down 200; 19.2uM; MCF7; HT_HG-U133A | 1.55e-05 | 198 | 166 | 9 | 4800_DN | |
| Drug | (1)-Nipecotic acid [498-95-3]; Down 200; 31uM; MCF7; HT_HG-U133A | 1.55e-05 | 198 | 166 | 9 | 6500_DN | |
| Drug | Methapyrilene hydrochloride [135-23-9]; Up 200; 13.4uM; MCF7; HT_HG-U133A | 1.61e-05 | 199 | 166 | 9 | 4990_UP | |
| Drug | Glafenine hydrochloride [65513-72-6]; Up 200; 9.8uM; MCF7; HT_HG-U133A | 1.61e-05 | 199 | 166 | 9 | 7418_UP | |
| Drug | Thyroxine (L) [51-48-9]; Down 200; 5.2uM; MCF7; HT_HG-U133A | RNF31 TICAM1 RNF19B NUP214 BCL3 PPFIA3 TBC1D22A RIPOR1 GARRE1 | 1.61e-05 | 199 | 166 | 9 | 3249_DN |
| Drug | Anisomycin [22862-76-6]; Up 200; 15uM; MCF7; HT_HG-U133A | 2.35e-05 | 160 | 166 | 8 | 5364_UP | |
| Drug | Anisomycin [22862-76-6]; Up 200; 15uM; MCF7; HT_HG-U133A | 2.57e-05 | 162 | 166 | 8 | 2658_UP | |
| Drug | Puromycin dihydrochloride [58-58-2]; Up 200; 7.4uM; MCF7; HT_HG-U133A | 3.34e-05 | 168 | 166 | 8 | 5310_UP | |
| Drug | Cycloheximide [66-81-9]; Up 200; 14.2uM; MCF7; HT_HG-U133A | 4.11e-05 | 173 | 166 | 8 | 3464_UP | |
| Drug | Azacytidine-5 [320-67-2]; Up 200; 16.4uM; MCF7; HT_HG-U133A | 6.60e-05 | 185 | 166 | 8 | 4128_UP | |
| Drug | 17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 6.86e-05 | 186 | 166 | 8 | 916_DN | |
| Drug | Gabexate mesilate [56974-61-9]; Down 200; 9.6uM; HL60; HT_HG-U133A | 8.25e-05 | 191 | 166 | 8 | 2937_DN | |
| Drug | Cyanocobalamin [68-19-9]; Down 200; 3uM; MCF7; HT_HG-U133A | 8.56e-05 | 192 | 166 | 8 | 4395_DN | |
| Drug | Tadjakonine [11087-94-8]; Down 200; 7.4uM; MCF7; HT_HG-U133A | 9.20e-05 | 194 | 166 | 8 | 4424_DN | |
| Drug | Nifedipine [21829-25-4]; Up 200; 11.6uM; PC3; HT_HG-U133A | 9.20e-05 | 194 | 166 | 8 | 1814_UP | |
| Drug | Tiabendazole [148-79-8]; Down 200; 19.8uM; MCF7; HT_HG-U133A | 9.20e-05 | 194 | 166 | 8 | 2840_DN | |
| Drug | Berberine chloride [633-65-8]; Up 200; 10.8uM; MCF7; HT_HG-U133A | 9.54e-05 | 195 | 166 | 8 | 2770_UP | |
| Drug | Mephenytoin [50-12-4]; Up 200; 18.4uM; HL60; HT_HG-U133A | 9.88e-05 | 196 | 166 | 8 | 6158_UP | |
| Drug | Fenofibrate [49562-28-9]; Up 200; 11uM; MCF7; HT_HG-U133A | 9.88e-05 | 196 | 166 | 8 | 7432_UP | |
| Drug | Epitiostanol [2363-58-8]; Down 200; 13uM; PC3; HT_HG-U133A | 9.88e-05 | 196 | 166 | 8 | 4204_DN | |
| Drug | 2-propylpentanoic acid; Up 200; 1000uM; PC3; HT_HG-U133A | 1.02e-04 | 197 | 166 | 8 | 4433_UP | |
| Drug | Althiazide [5588-16-9]; Up 200; 10.4uM; MCF7; HT_HG-U133A | 1.02e-04 | 197 | 166 | 8 | 6829_UP | |
| Drug | Dihydroergotamine tartrate [5989-77-5]; Up 200; 3uM; MCF7; HT_HG-U133A | 1.02e-04 | 197 | 166 | 8 | 6840_UP | |
| Drug | Orphenadrine hydrochloride [341-69-5]; Up 200; 13uM; HL60; HT_HG-U133A | 1.02e-04 | 197 | 166 | 8 | 2356_UP | |
| Drug | Flumequine [42835-25-6]; Up 200; 15.4uM; HL60; HG-U133A | 1.02e-04 | 197 | 166 | 8 | 1429_UP | |
| Drug | CpG ODN 1826 | 1.03e-04 | 13 | 166 | 3 | ctd:C423449 | |
| Drug | Tacrine hydrochloride hydrate [1684-40-8]; Up 200; 15.8uM; PC3; HT_HG-U133A | 1.06e-04 | 198 | 166 | 8 | 6698_UP | |
| Drug | Neostigmine bromide [114-80-7]; Up 200; 13.2uM; HL60; HT_HG-U133A | 1.06e-04 | 198 | 166 | 8 | 2432_UP | |
| Drug | Apramycin [37321-09-8]; Down 200; 7.4uM; MCF7; HT_HG-U133A | 1.06e-04 | 198 | 166 | 8 | 7334_DN | |
| Drug | Tranexamic acid [1197-18-8]; Down 200; 25.4uM; PC3; HT_HG-U133A | 1.06e-04 | 198 | 166 | 8 | 2085_DN | |
| Drug | Dimenhydrinate [523-87-5]; Up 200; 8.6uM; MCF7; HT_HG-U133A | 1.06e-04 | 198 | 166 | 8 | 7431_UP | |
| Drug | Ethaverine hydrochloride [985-13-7]; Up 200; 9.2uM; MCF7; HT_HG-U133A | 1.10e-04 | 199 | 166 | 8 | 5337_UP | |
| Drug | Folic acid [59-30-3]; Down 200; 9uM; PC3; HT_HG-U133A | 1.10e-04 | 199 | 166 | 8 | 5844_DN | |
| Drug | Isoconazole [27523-40-6]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 1.10e-04 | 199 | 166 | 8 | 7211_DN | |
| Drug | CP-690334-01 [459212-38-5]; Down 200; 1uM; MCF7; HT_HG-U133A | 1.10e-04 | 199 | 166 | 8 | 4383_DN | |
| Drug | Cinnarizine [298-57-7]; Down 200; 10.8uM; PC3; HT_HG-U133A | 1.10e-04 | 199 | 166 | 8 | 5817_DN | |
| Drug | Austricine [10180-88-8]; Down 200; 14.2uM; HL60; HT_HG-U133A | 1.14e-04 | 200 | 166 | 8 | 2157_DN | |
| Drug | Dimaprit dihydrochloride [23256-33-9]; Up 200; 17uM; MCF7; HT_HG-U133A | 1.14e-04 | 200 | 166 | 8 | 7480_UP | |
| Disease | Microcephaly | 3.44e-05 | 67 | 162 | 5 | C0025958 | |
| Disease | cortical thickness | FOXO3 SHROOM3 ZNF474 TM7SF3 SPECC1 MICALL1 VPS13D TBC1D22A SH3PXD2A NFKB1 CPEB4 FOXL2NB IQCJ-SCHIP1 CAMTA1 AGBL2 SH3RF3 ARHGAP21 PDZD2 | 4.31e-05 | 1113 | 162 | 18 | EFO_0004840 |
| Disease | neuroimaging measurement | FOXO3 SHROOM3 UBAP2 ZNF474 SZT2 PODXL KIF1B BRSK2 SYNJ1 SH3PXD2A CPEB4 FOXL2NB IQCJ-SCHIP1 CAMTA1 DMRT1 SH3RF3 WWC1 | 8.72e-05 | 1069 | 162 | 17 | EFO_0004346 |
| Disease | serine/threonine-protein kinase BRSK2 measurement | 8.95e-05 | 3 | 162 | 2 | EFO_0803063 | |
| Disease | Atypical juvenile parkinsonism | 8.95e-05 | 3 | 162 | 2 | C4510873 | |
| Disease | Colorectal Carcinoma | SHANK1 ERCC6 SALL3 TCOF1 PARP8 APC2 CORO1B KCNH4 HIVEP3 BRAF NPAP1 LZTS2 PIK3R5 | 1.42e-04 | 702 | 162 | 13 | C0009402 |
| Disease | Episodic Ataxia | 1.78e-04 | 4 | 162 | 2 | C1720189 | |
| Disease | Thyroid preparation use measurement | 2.05e-04 | 217 | 162 | 7 | EFO_0009933 | |
| Disease | Metastatic melanoma | 2.24e-04 | 54 | 162 | 4 | C0278883 | |
| Disease | disease prognosis measurement | 4.43e-04 | 6 | 162 | 2 | EFO_0007936 | |
| Disease | cortical surface area measurement | FOXO3 SHROOM3 ZNF474 BAZ2B PODXL KIF1B BRSK2 FCHO2 CELF2 TBC1D22A NFKB1 CPEB4 FOXL2NB SH3RF3 TNXB ARHGAP21 WWC1 PDZD2 | 4.46e-04 | 1345 | 162 | 18 | EFO_0010736 |
| Disease | mean arterial pressure | SZT2 PODXL HECTD4 HIVEP3 CCNT2 TTBK1 ZFP36L1 RPTOR CPEB4 RAB11FIP5 | 4.59e-04 | 499 | 162 | 10 | EFO_0006340 |
| Disease | brain volume measurement | FOXO3 EPS15 ZNF474 SZT2 BRSK2 SPECC1 ZFP36L1 SH3PXD2A NFKB1 CAMTA1 AGBL2 | 4.71e-04 | 595 | 162 | 11 | EFO_0006930 |
| Disease | glutamate measurement | 5.34e-04 | 29 | 162 | 3 | EFO_0010487 | |
| Disease | urate measurement, bone density | DAB2IP UBE4B BAZ2B PODXL RIPOR3 RIPK4 CNTNAP5 SALL2 SH3RF3 TNXB PDZD2 | 6.53e-04 | 619 | 162 | 11 | EFO_0003923, EFO_0004531 |
| Disease | pulse pressure measurement | FOXO3 SHROOM3 PODXL NEK10 PCDHAC1 SRCAP CEP164 MADD KCNH4 HIVEP3 TGIF1 TTBK1 CELF2 RPTOR TMEM270 IQCJ-SCHIP1 AGBL2 GARRE1 | 6.66e-04 | 1392 | 162 | 18 | EFO_0005763 |
| Disease | reticulocyte count | FOXO3 UBAP2 HECTD4 IST1 GMEB2 KANK2 ITGAX SPECC1 BIRC6 ZFP36L1 NFKB1 CPEB4 IRS2 MYRF PDZD2 | 6.71e-04 | 1045 | 162 | 15 | EFO_0007986 |
| Disease | platelet component distribution width | FOXO3 TENT4A HEATR4 RIPOR3 VWA7 MICALL1 MAVS ZFP36L1 IRS2 CAMTA1 AGBL2 TNXB | 9.88e-04 | 755 | 162 | 12 | EFO_0007984 |
| Disease | atrial fibrillation | 1.07e-03 | 371 | 162 | 8 | EFO_0000275 | |
| Disease | obsolete_red blood cell distribution width | ASXL1 ARHGAP23 TENT4A BAZ2B HECTD4 RELB FCHO2 KANK2 ITGAX BIRC6 ZFP36L1 CPEB4 IRS2 MUC4 GARRE1 ARHGAP21 CDH18 | 1.23e-03 | 1347 | 162 | 17 | EFO_0005192 |
| Disease | otitis media (is_marker_for) | 1.31e-03 | 10 | 162 | 2 | DOID:10754 (is_marker_for) | |
| Disease | age at menopause | 1.45e-03 | 302 | 162 | 7 | EFO_0004704 | |
| Disease | mean platelet volume | KIF1B TM7SF3 NACA FCHO2 SRCAP VWA7 GORASP2 CELF2 ZFP36L1 CPEB4 RIPOR1 IRS2 CAMTA1 PSMG4 | 1.55e-03 | 1020 | 162 | 14 | EFO_0004584 |
| Disease | Microphthalmos | 1.59e-03 | 11 | 162 | 2 | C0026010 | |
| Disease | Macrocephaly | 1.59e-03 | 11 | 162 | 2 | C0221355 | |
| Disease | nucleus accumbens volume change measurement | 1.59e-03 | 11 | 162 | 2 | EFO_0021493 | |
| Disease | cysteine-glutathione disulfide measurement | 1.59e-03 | 11 | 162 | 2 | EFO_0021001 | |
| Disease | testosterone measurement | SHROOM3 CCDC85C SRCAP BIRC6 ARHGAP6 TTBK1 ZFP36L1 SH3PXD2A NFKB1 CPEB4 TNKS2 SMCR5 MMP12 DNMBP SDC1 ARHGAP21 | 1.81e-03 | 1275 | 162 | 16 | EFO_0004908 |
| Disease | Pulmonary Thromboembolisms | 1.91e-03 | 12 | 162 | 2 | C0524702 | |
| Disease | Pulmonary Embolism | 1.91e-03 | 12 | 162 | 2 | C0034065 | |
| Disease | linoleoyl-arachidonoyl-glycerol (18:2/20:4) [2] measurement | 1.91e-03 | 12 | 162 | 2 | EFO_0800500 | |
| Disease | brain disease (is_implicated_in) | 1.91e-03 | 12 | 162 | 2 | DOID:936 (is_implicated_in) | |
| Disease | Gastric Adenocarcinoma | 1.95e-03 | 45 | 162 | 3 | C0278701 | |
| Disease | reticulocyte measurement | FOXO3 UBAP2 MKRN1 HECTD4 IST1 KANK2 ITGAX SPECC1 BIRC6 NFKB1 CPEB4 IRS2 ARHGAP21 PDZD2 | 2.07e-03 | 1053 | 162 | 14 | EFO_0010700 |
| Disease | X-24588 measurement | 2.25e-03 | 13 | 162 | 2 | EFO_0800898 | |
| Disease | developmental disorder of mental health (implicated_via_orthology) | 2.49e-03 | 49 | 162 | 3 | DOID:0060037 (implicated_via_orthology) | |
| Disease | Neoplasm of lung | 2.61e-03 | 14 | 162 | 2 | cv:C0024121 | |
| Disease | Lung cancer | 2.61e-03 | 14 | 162 | 2 | cv:C0242379 | |
| Disease | LUNG CANCER | 2.61e-03 | 14 | 162 | 2 | 211980 | |
| Disease | revision of total hip arthroplasty | 2.61e-03 | 14 | 162 | 2 | EFO_0020973 | |
| Disease | Gastrointestinal Stromal Tumors | 2.64e-03 | 50 | 162 | 3 | C0238198 | |
| Disease | Oral ulcer | 2.91e-03 | 107 | 162 | 4 | HP_0000155 | |
| Disease | plasminogen activator inhibitor 1 measurement | 3.28e-03 | 54 | 162 | 3 | EFO_0004792 | |
| Disease | Acute Cerebrovascular Accidents | 3.28e-03 | 54 | 162 | 3 | C0751956 | |
| Disease | nervousness | 3.42e-03 | 16 | 162 | 2 | NCIT_C74532 | |
| Disease | vital capacity | FOXO3 AHI1-DT SHROOM3 ZNF474 PODXL PCLO PCDHAC1 SIX4 WDR26 BRAF BOP1 RIPOR1 TNXB OTOG PDZD2 | 3.44e-03 | 1236 | 162 | 15 | EFO_0004312 |
| Disease | free cholesterol measurement | 3.54e-03 | 113 | 162 | 4 | EFO_0008591 | |
| Disease | response to homoharringtonine, cytotoxicity measurement | 3.86e-03 | 17 | 162 | 2 | EFO_0006952, EFO_0006996 | |
| Disease | systemic lupus erythematosus, COVID-19 | 4.02e-03 | 58 | 162 | 3 | MONDO_0007915, MONDO_0100096 | |
| Disease | von Willebrand factor measurement, coronary artery disease | 4.14e-03 | 118 | 162 | 4 | EFO_0001645, EFO_0004629 | |
| Disease | Tourette syndrome, schizophrenia | 4.33e-03 | 18 | 162 | 2 | EFO_0004895, MONDO_0005090 | |
| Disease | blood nickel measurement | 4.39e-03 | 120 | 162 | 4 | EFO_0007583 | |
| Disease | factor VIII measurement, Ischemic stroke | 4.82e-03 | 19 | 162 | 2 | EFO_0004630, HP_0002140 | |
| Disease | Cerebrovascular accident | 4.85e-03 | 62 | 162 | 3 | C0038454 | |
| Disease | hypothyroidism | 4.94e-03 | 284 | 162 | 6 | EFO_0004705 | |
| Disease | cholangiocarcinoma (is_marker_for) | 5.30e-03 | 64 | 162 | 3 | DOID:4947 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VASASPSSSISGLAG | 66 | A8MUN3 | |
| LLCTSPLSHSTGSDS | 36 | Q14137 | |
| GSELSTTSPSGTSLA | 566 | Q96MC4 | |
| SLAETALTSGSSPSA | 306 | P15056 | |
| STTSSALGALTSPVA | 306 | O95319 | |
| SELDLSKLSPSSSSS | 2071 | Q9HCK8 | |
| SPVGLSSDGISSSSS | 601 | O60583 | |
| AASSLTLTAGSSLLP | 556 | Q9Y6Y1 | |
| EAVTLSTSLPLSSSS | 4581 | Q9NR09 | |
| LTGSLTGSTLSSVSP | 516 | P54646 | |
| ESQSPAFLGTSSSTL | 711 | Q9UIF8 | |
| SITVSASGTSPGLSA | 671 | P06731 | |
| APLARAESSSSISSS | 501 | Q0JRZ9 | |
| STTTAADATPSGSLA | 431 | Q9BR76 | |
| RVSSISPGSATLLSS | 86 | Q9Y2Z9 | |
| STAGSSPNSVSELSL | 356 | Q5M775 | |
| LSTSESGELGSSLSS | 1601 | Q6RI45 | |
| TLLSSQSSSLVAPSG | 756 | Q6XZF7 | |
| LSETSPSSTSASALD | 66 | Q53GS7 | |
| ASATGSLDLSSDFLS | 16 | Q6PL18 | |
| GPRSSVTTLSASALS | 31 | P0C7V0 | |
| DADSSSGPLASSSLL | 1376 | Q03468 | |
| SPSSSSSGSLALGSA | 201 | Q8IXJ9 | |
| DLSGARVSLSSPTSA | 181 | Q9UKD1 | |
| SSLAASSSLSSIVGP | 161 | Q13434 | |
| GTASTASKEPLTTSL | 1731 | Q9HC84 | |
| VSSACSSSPDGLLST | 266 | A6NNM3 | |
| SSSPDGLLSTHASSL | 271 | A6NNM3 | |
| VSSACSSSPDGLLST | 266 | A6NJZ7 | |
| SSSPDGLLSTHASSL | 271 | A6NJZ7 | |
| SSISGSLPSSGSLQA | 356 | Q9BXF6 | |
| GSPDLSSLSLAVSRS | 36 | Q01201 | |
| SLGLSLASTTSPSQL | 91 | P20702 | |
| ATASGALPLNSSTSL | 11 | P39900 | |
| SLLTSTEGLCPSALS | 531 | Q8IZ07 | |
| DLASTPGSGSSSISA | 666 | Q5VWQ8 | |
| TASTSRKTSLFLGPS | 3046 | Q8WXI7 | |
| GATSLSAPTLDTSAT | 4101 | Q8WXI7 | |
| SLYSAVSGSSPTSAL | 5941 | Q8WXI7 | |
| SSLPSASSFSGEILT | 5981 | Q8WXI7 | |
| EETSSASSLLSLPAT | 8261 | Q8WXI7 | |
| TSTVDLGTSGTPSSL | 12986 | Q8WXI7 | |
| LPVTGLSSASTGDTT | 3361 | Q99102 | |
| TSLSSVSTGDTTPLL | 3636 | Q99102 | |
| ASGVSPSDLSAIATT | 101 | Q9H4B0 | |
| LPTLASQSAGITASS | 256 | O00592 | |
| PLTATDTAILSGSLS | 171 | Q9NVH1 | |
| LIGILTPSSSSSSQL | 461 | Q8N3A8 | |
| ASSASVPTLASTLGE | 506 | Q8IVU1 | |
| SESGSSLQPLSADST | 136 | Q8WXG6 | |
| TLSDSGRNSLSSLPT | 216 | Q9BRK4 | |
| SSDLAALSPLTSSGH | 181 | Q7Z434 | |
| VPESSSAASSGELLS | 371 | Q9H8Y8 | |
| SLTSSRGSLVASSLD | 441 | Q8IX03 | |
| APTSAAALGSTSSIA | 1116 | Q86Z02 | |
| GSASLEPLSSSRAAA | 106 | Q6ZUU3 | |
| LATSESLSPLTSLSG | 426 | Q9UN88 | |
| LSDSLSPSLSSGTLS | 1526 | O60333 | |
| SSSLAGTPSDETLAT | 786 | O75145 | |
| SIPTSLTALSLASAS | 626 | O75335 | |
| ISSPVLSLSTSSSSG | 766 | Q2LD37 | |
| TAVNSLGSSSSLPST | 201 | Q99665 | |
| RSISGASSGLSTSPL | 411 | Q8IWQ3 | |
| SRSSIDSQASLSGPL | 176 | A6NKD9 | |
| LSSKPSSETASSGLT | 306 | Q9NXV6 | |
| SPLDSGSLTSLDSSV | 11 | Q6PIU1 | |
| LSGASLTDSTSSATL | 2111 | Q9Y6V0 | |
| LDISDNSSSSSSSPL | 906 | Q6ZWH5 | |
| SLSGLGDSTEPSLSS | 1536 | O15018 | |
| SSSRLLGSASPSSSV | 41 | P41219 | |
| LGFSKSSSPSASLTE | 611 | O96028 | |
| SESLGSSSDKTLPSI | 711 | Q9UQ05 | |
| LSFGSLLSSATTPSL | 1471 | P35658 | |
| PVSLSTNSSLASSGE | 551 | Q8N3F8 | |
| SSPLLDLSSSSESTE | 296 | Q9ULI3 | |
| ATAPTSSATTGLSLC | 226 | P37198 | |
| LAASGPRSLSTSAIS | 56 | Q15070 | |
| RASPSATLAALTGST | 91 | Q9Y4D8 | |
| ASSLVSGLNSSASEP | 191 | Q86U44 | |
| SLSSPQLLSSGSSAS | 576 | Q5XG87 | |
| TTTAPLFTGLASATS | 386 | A6NF01 | |
| SSALSSAVTSGLASL | 486 | Q86XN7 | |
| SAVTSGLASLSSLTL | 491 | Q86XN7 | |
| LPGSLIATSSTAATS | 721 | Q86XN7 | |
| PSSTAAVLSGLSASA | 741 | Q86XN7 | |
| GPSASSLLAVESSSG | 491 | Q9H158 | |
| SVLAGPASSRSASSI | 141 | O43182 | |
| SSLLSASSPASSLGS | 946 | Q9Y4H2 | |
| SSLGSFESPSIASSI | 1166 | O95996 | |
| ALGDAPSTSVSLTTA | 456 | Q96EP1 | |
| SSLSSASAEKGSPIL | 96 | Q9NZH6 | |
| VPDSSSLSSLGDSSF | 1481 | P49454 | |
| GNATSATLGPLSSST | 606 | Q9P218 | |
| LITALGTSSSSATLP | 356 | P43003 | |
| SLDASPSSSAGSLQT | 2016 | Q9P0X4 | |
| PSSSAGSLQTTLEDS | 2021 | Q9P0X4 | |
| SATLSSSLSPADTLD | 616 | O75417 | |
| ASTATTAPLGSLTAA | 46 | O15063 | |
| NGLSIPLSSSESSST | 1051 | Q96RY5 | |
| FLGSSSPLTGDTSLA | 121 | Q86WZ0 | |
| SDSARLPISSGSTSS | 676 | Q9Y653 | |
| STSGSDSSLSDGLPV | 716 | Q5U5Z8 | |
| RSVSGASTGLSSSPL | 431 | Q8TDC3 | |
| SDGGIPSLSSSSTLT | 571 | Q13634 | |
| DTLPTASAGASTSAS | 331 | P53990 | |
| GSLTPSAAGSTASLV | 146 | Q63ZY3 | |
| CLLKTSESGTPSSST | 256 | P03952 | |
| SLTATQSFSELSSGP | 351 | Q9ULL0 | |
| LGTSTQPLTSSASSL | 151 | Q17RY0 | |
| TSSPLLISGTSAAEL | 106 | P42566 | |
| TSPESSSRLSSNGLL | 381 | P20749 | |
| SSRLSSNGLLSASPS | 386 | P20749 | |
| TLLSTSAGTATAPGL | 491 | Q9Y467 | |
| AGSPALSESSSSQAL | 891 | Q9BXA9 | |
| GDPSASLTLLSLSSI | 826 | P80192 | |
| LSSSLPSATLGSLLD | 251 | Q8WYK1 | |
| CSSSSDLSLLLGPSF | 631 | Q8N137 | |
| DSGLVSLSSSSPISN | 331 | Q9Y5R6 | |
| ASGLTLSSALTSTPA | 131 | Q9BVL2 | |
| LSSALTSTPAASTGF | 136 | Q9BVL2 | |
| TPAAASLSTATDGLA | 1781 | Q6ZRI0 | |
| SSLAASSSLSSIVGP | 126 | Q9UHC7 | |
| VGSASITAFPSLSSS | 636 | Q9H195 | |
| SLSGSSLYSTSANLP | 586 | O43524 | |
| LSASGEGSLTFPSSL | 331 | Q14D33 | |
| LVSGRSASSSLASLS | 776 | Q5T011 | |
| SLSSRSLALAAAPSS | 26 | Q9H2W6 | |
| SVLSTSGSPTDGLSV | 491 | Q6ZMZ0 | |
| EISSSSSGLPYASSL | 181 | Q9Y651 | |
| ISIALPSSTSSTLLG | 986 | O43426 | |
| ASTNSSVLGADLPSS | 106 | Q13428 | |
| SSALGILSTPSFSTK | 796 | Q5TCX8 | |
| VSSACSSSPDGLLST | 266 | Q9UFD9 | |
| SSSPDGLLSTHASSL | 271 | Q9UFD9 | |
| LALSSLQATTSLGSP | 606 | Q9H6K5 | |
| VSSLSLTQLAGPSSA | 831 | Q8IWB4 | |
| SSLSSSSPSLFDGAV | 681 | Q96Q15 | |
| PLSSSSDGITNLSLS | 311 | Q9UIU6 | |
| SGLASASSLSSLREP | 1131 | Q8TF72 | |
| SRTPSLLASSHSASG | 66 | Q8TEV8 | |
| TGLEATAASTSTLPA | 81 | P18827 | |
| AGSAPSLINSSSTLL | 1156 | P41252 | |
| GSSSSLAASASLFPL | 941 | Q15714 | |
| SSSSPGGSLDLVSAL | 136 | B3KU38 | |
| SLLGDTSDTTSTGLA | 66 | Q5JS54 | |
| SASALTLGLATAPSL | 1501 | Q6ZRS2 | |
| TLGLATAPSLSSSQT | 1506 | Q6ZRS2 | |
| PDTSTLVSSASAASL | 801 | Q9NZP6 | |
| LSRSSSESKLPSSGS | 401 | P57078 | |
| PGNLSTSSSASSTLG | 756 | Q8N122 | |
| APTTKLSSGTLRSAS | 476 | Q9Y566 | |
| SLFSPASCSILSGSS | 356 | Q9UPE1 | |
| GSLARFSALSSATPT | 1316 | Q9UPV0 | |
| VSGSSLLPSLSASSD | 236 | Q6UE05 | |
| LLPSLSASSDSESGT | 241 | Q6UE05 | |
| STSLLALGDSSLSSP | 281 | Q96EP0 | |
| LPSSELASSSTDSSG | 841 | Q15735 | |
| SSLATPSALLGSSCA | 66 | Q15583 | |
| LLGPSSTSEAVGSSS | 156 | Q5SXH7 | |
| VSSLSLTQLAGPSSA | 831 | Q5VYP0 | |
| AATAAATGLLDSPTS | 211 | Q07352 | |
| GDLTSSPLSQLSSSL | 691 | Q5T6F2 | |
| LLLRLASGASSSSSE | 1101 | Q5TCY1 | |
| LEAPSSLTPSSELSS | 486 | Q2QGD7 | |
| VSSLSLTQLAGPSSA | 831 | Q5TZJ5 | |
| DSTLSLASSQASGPA | 356 | Q8WYR1 | |
| TSTSASTSDVGFLPL | 416 | Q96MK2 | |
| VSSLSLTQLAGPSSA | 831 | Q5VU36 | |
| SGSLSSLATATRPAL | 556 | Q8TEJ3 | |
| DSDSPGSSSLSLTRK | 641 | Q5TCZ1 | |
| STGSPASLASNLEIS | 196 | Q8IUC6 | |
| GLSSLESTKARAPSS | 1446 | Q9P227 | |
| AALGRGSLTPSSSSS | 111 | Q2MJR0 | |
| GVSSLSSSPSNSLET | 81 | O95155 | |
| ELTVTGSSPDSLSLS | 2416 | P22105 | |
| ELTVTGSSPDSLSLS | 2741 | P22105 | |
| ELTVTGSSPDSLSLS | 3171 | P22105 | |
| SSESILSLEGSSSTA | 1411 | Q5T1R4 | |
| GSSSISAGSLTSLSL | 1546 | Q92576 | |
| SATVTLGGTSDPSTL | 171 | Q8WUA7 | |
| LGGTSDPSTLSSSAL | 176 | Q8WUA7 | |
| SPSSLSAASSLDNLS | 831 | Q9H2K2 | |
| ESLGSPSSLSSSQAS | 11 | Q8NA96 | |
| STLSPNLTSSTESLG | 41 | Q8NA96 | |
| TESLGYLSSLSSSQP | 51 | Q8NA96 | |
| GLLSSDSYSSLSPET | 31 | Q6S9Z5 | |
| SATTAASSSLATPEL | 96 | Q9H7D7 | |
| QAPSSSSLDAGTLSD | 2846 | Q5T4S7 | |
| TGSSSSTLASTNRPL | 1896 | Q5T5U3 | |
| SPSTSLELATLSSPS | 681 | Q6ZS17 | |
| TPASSLSFVLDTTGS | 311 | Q9Y334 | |
| LSSLTGAPGTTAVSS | 366 | Q8N7P7 | |
| SPTLLSNSSETGTAS | 81 | Q9NS93 | |
| KSLSLASTSRDSPGA | 2681 | Q5THJ4 | |
| TEATLSPGSTTASSL | 1506 | Q9UKN1 | |
| GSTDTALSPGSTTAL | 2141 | Q9UKN1 | |
| STDTALSPGSTTALS | 2616 | Q9UKN1 | |
| ETTALPGSTTTAGLS | 3231 | Q9UKN1 | |
| TEATLSPGSTTASSL | 4146 | Q9UKN1 | |
| SGSLNVATSFSLSPT | 396 | E9PAV3 | |
| LLVTTSLTSSAPGSA | 856 | Q9Y2G1 | |
| LSFTESLTSGASLLT | 936 | P19838 |